Article
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses
1 Jul 2025
Abstract excerpt
The first-ever recent Marburg virus (MARV) outbreak in Tanzania and recent emergences in Rwanda, Ghana and Equatorial Guinea underscore the importance of therapeutic or vaccine development against the virus, for which none are approved. mRNA vaccines were proven successful in a pandemic-response to severe acute respiratory syndrome coronavirus-2, making it an appealing platform to target pathogenic emerging...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
